Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

GeneDx Holdings (WGS) Operating Income (2020 - 2025)

Historic Operating Income for GeneDx Holdings (WGS) over the last 6 years, with Q3 2025 value amounting to -$3.3 million.

  • GeneDx Holdings' Operating Income rose 5821.34% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.0 million, marking a year-over-year increase of 11728.0%. This contributed to the annual value of -$23.2 million for FY2024, which is 8714.64% up from last year.
  • As of Q3 2025, GeneDx Holdings' Operating Income stood at -$3.3 million, which was up 5821.34% from $9.0 million recorded in Q2 2025.
  • In the past 5 years, GeneDx Holdings' Operating Income ranged from a high of $9.0 million in Q2 2025 and a low of -$324.9 million during Q4 2022
  • Over the past 5 years, GeneDx Holdings' median Operating Income value was -$45.4 million (recorded in 2021), while the average stood at -$69.3 million.
  • Its Operating Income has fluctuated over the past 5 years, first crashed by 25787.93% in 2022, then surged by 18469.61% in 2025.
  • GeneDx Holdings' Operating Income (Quarter) stood at -$115.8 million in 2021, then plummeted by 180.6% to -$324.9 million in 2022, then soared by 92.11% to -$25.6 million in 2023, then skyrocketed by 134.34% to $8.8 million in 2024, then crashed by 136.92% to -$3.3 million in 2025.
  • Its Operating Income was -$3.3 million in Q3 2025, compared to $9.0 million in Q2 2025 and -$4.6 million in Q1 2025.